This is an observational, cross-sectional study that the main objective is to describe the patient clinical profile that begins with disseminated Her 2+ Breast Cancer or develops a metastasis after or during the adjuvant treatment.
Study Type
OBSERVATIONAL
Enrollment
129
The Patient Clinical Profile (General Clinical Data and Breast Cancer Characteristics)
General clinical data: age, weigh, height, Perfomance Status (ECOG Eastern Cooperative Oncology Group, runs from 0 to 5, with 0 denoting perfect health and 5 death), Breast cancer characteristics: familiar history of breast cancer, initial diagnostic (localized or disseminated), age at diagnostic, TNM (tumor node metástasis), tumor size, node involvement, primary tumor surgery, HER2 overexpression, histological Classification (grades I, II and III,determines the urgency and aggressiveness of treatment, as the higher grades do tend to correspond to poorer survival rates and prognosis), time from the primary breast cancer to distant relapse, description and localization of metastasis
Time frame: 1 day (there is no follow-up, it is a cross-sectional study)
Adjuvant Treatment in Primary Breast Cancer: Chemotherapy (Treatment With TAC-Docetaxel, Adriamicine and Cyclophosphamide), Hormonal Therapy Anti-HER Biological Therapy
Time frame: one day (there is no follow-up, it is a cross-sectional study)
The Pattern of Treatment in Metastatic Breast Cancer: Chemotherapy, Hormonal Therapy Anti-HER Biological Therapy
Time frame: one day (there is no follow-up, it si a cross-sectional study)
Adjuvant Treatment and Age
Adjuvant treatment and clinical profile (age) The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66)
Time frame: one day (there is no follow-up, it is a cross-sectional study)
Adjuvant Treatment-Physical Activity
Adjuvant treatment and clinical profile (Physical activity) The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66)
Time frame: one day (there is no follow-up, it is a cross-sectional study)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital de Denia
Denia, Alicante, Spain
Hospital General de Elda
Elda, Alicante, Spain
Hospital de Torrecárdenas
Almería, Almería, Spain
Hospital Infanta Cristina de Badajoz
Badajoz, Badajoz, Spain
Hospital don Benito
Don Benito, Badajoz, Spain
Hospital de Llerena
Llerena, Badajoz, Spain
Hospital de Mérida
Mérida, Badajoz, Spain
Hospital Son Llàtzer
Palma de Mallorca, Balearic Islands, Spain
ICO Badalona
Badalona, Barcelona, Spain
Clínica Corachan
Barcelona, Barcelona, Spain
...and 29 more locations
Adjuvant Treatment-Node Affectation
Adjuvant treatment and clinical profile (Node affectation) The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66)
Time frame: one day (there is no follow-up, it is a cross-sectional study)
Disseminated Breast Cancer Treatment-Age
Analyse disseminated Breast Cancer treatment and clinical profile (age)
Time frame: one day (there is no follow-up, it is a cross-sectional study)
Disseminated Breast Cancer Treatment-physical Activity
Analyse disseminated Breast Cancer treatment and clinical profile (physical activity)
Time frame: one day (there is no follow-up, it is a cross-sectional study)
Disseminated Breast Cancer Treatment-Smoking
Analyse disseminated Breast Cancer treatment and clinical profile (Smoking)
Time frame: one day (there is no follow-up, it is a cross-sectional study)